Perk Brings Its Spend Platform to U.S.: NYSE Content Update

    0
    16

    NYSE issues a pre-market daily advisory direct from the trading floor.

    NEW YORK, Sept. 15, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

    ServiceNow on mission to help firms see AI ROI

    Ashley Mastronardi delivers the pre-market update on September 15th

    • Perk is looking to accelerate its growth in the U.S.
      • Announcement comes after the launch of Perk Spend in Europe, where up to 40% of new deals are for the combined Travel and Spend offering.
      • Perk’s research found that one in four U.S. companies still have no formal look for managing spend.
      • Nikita Miller, Perk’s Chief Product Officer, will join NYSE Live to discuss how the solution is bringing control and flexibility to finance leaders.
    • ServiceNow President Amit Zavery will join NYSE Live.
      • The company says that its AI Control Tower, Context Engine, and Shift Zero solutions solve the biggest questions customers have.
      • ServiceNow (NYSE: NOW) is looking to guide enterprises through the new tech ecosystem, where AI agents are moving from answering questions to taking action.
    • The U.S. 10-Year Treasury yield surpasses 5% and hits highest level since 2007.
      • The move comes as the Federal Reserve commences its two-day meeting, with a decision on interest rates due Wednesday.
      • As of 8 a.m. ET, ICE Brent Crude is trading at $106 a barrel amid the ongoing conflict in the Middle East.

    Opening Bell
    Ingram Micro (NYSE: INGM) marks their 2026 Capital Markets Day

    Closing Bell
    Jackson Financial  (NYSE: JXN) celebrates five years of being listed on the NYSE

    For market insights, IPO activity, and today’s opening bell, download the NYSE TV App and check out the NYSE YouTube: TV.NYSE.com and YouTube.com/@NYSEofficial

    Teva Pharmaceuticals at NYSE September 14
    Teva Pharmaceuticals at NYSE September 14